Who We Are

We are a company comprised of Corporate and Scientific industry leaders committed to the mission-driven product development of Hydrosome H2O. Based on science and research findings, we believe Hydrosome H2O has the potential to positively impact market categories, creating opportunities for strategic partnerships to develop applications of our technology within their products. With Hydrosome H2O’s water advancing capabilities, we are devoted to making remarkable impacts on everyday life.

Our Mission

To positively impact everyday life by enhancing the bioavailability of water and advancing its function across various water-based applications.

Get to know us

Meet the Hydrosome Labs Team

Our Leadership Team

We are ready to help with any questions.

GadbutPaul_web21

Paul Gadbut

President & CEO

Paul’s immediate past include Managing Partner, of a corporate asset management firm. In addition, he has served in executive positions with several Financial Institutions

ChamberlainJay_web2

Jay Chamberlain

COO

Prior to joining he had a 30+ year career in global transportation & logistics and was one of the largest franchisees of a $4 Billion franchise rollup. He has also been active in real estate investing and startups.

JacobsBob_web2

Bob Jacobs

President Consumer Products

Bob is a consumer products veteran with 20+ years of experience working in various roles at Procter and Gamble. In addition, he has experience across various industries, serving as Chief Brand Officer for Volvo Car Group – Americas and a brand leader at Starwood Hotels.

Thierry-Saint-Denis

Dr. Thierry Saint-Denis

Chief Science Officer

Thierry has 25 years of experience leading Nutrition Science, Innovation and Product Development teams in the Food & Beverage industry. He is named inventor in multiple patents in the fields of functional foods & beverages, and in the past 10 years he spearheaded the design and launch of several blockbuster food products that are consumed by millions of consumers every day.

Peter Kozak PhD.

Head of Engineering

Peter has a PhD in Mechanical and Aerospace Engineering from Illinois Institute of Technology and a BS from the University of Arizona. He brings years of experience in Fluid Dynamics, working for Argonne National Labs on nuclear centrifuge and wind turbine design.

Our Advisors

EdmondsChris_web2

Chris Edmonds

Investor Advisor
Is the Global Head of Clearing & Risk at Intercontinental Exchange, Inc. (NYSE: ICE). Edmonds oversees all of ICE’s clearing house operations and the global risk management team. He serves as Chairman of Hydrosome Labs, LLC
JamesChow

James Chow

Investor Advisor
James Chow is Chief Financial Officer at Oak Street Health. Prior to Oak Street, James spent over 20 years in different leadership roles in startups and turnarounds in the managed care space. He is a Certified Public Accountant
CBL_5

Chris Lorenzen

Investor Advisor
Founder and Chief Executive Officer of Eagle Seven Holdings, LP which includes Eagle Seven, LLC and Eagle Seven Technologies, LLC both based in Chicago, Illinois.  Chris has spent his entire career involved in nearly every aspect of trading and technology from equities to derivatives.
AufieroTina_web2

Martina F. Aufiero

Advisor
Chief Financial Officer at Isoolate, an innovative technology startup. Tina has 20+ years of experience in the Technology sector as both an Investor & Operator. Tina has held numerous board positions and has been an advisor to several tech accelerators. She has been named to the Institutional Investors' FinTech Finance 40.

Our Scientific Advisors

ZentnerGaylen_web2

Gaylen M. Zentner PhD.

Scientific Advisor
Dr. Zentner holds a Ph.D. in Pharmaceutical Chemistry from the University of Utah. Scientific expertise is focused on formulation development and all technical activities supporting both drug substance and drug product sections of Chemistry, Manufacturing & Control (CMC) regulatory submissions where he has 40 years of pertinent experience.
RusconiBill_0821web2

William Rusconi

Scientific Advisor
Bill has over 30 years’ experience in drug, device, diagnostics and consumer products and has held senior management positions ranging from start-ups to the Fortune 50 including, Procter and Gamble, Baxter Healthcare and Myriad Genetics. Mr. Rusconi earned his BS in Molecular Biology from Vanderbilt University and MBA from the Kellogg Graduate School of Management at Northwestern University

Our Leadership Team

Paul Gadbut

President & CEO

Paul’s immediate past include Managing Partner, of a corporate asset management firm. In addition, he has served in executive positions with several Financial Institutions

Jay Chamberlain

COO

Prior to joining he had a 30+ year career in global transportation & logistics and was one of the largest franchisees of a $4 Billion franchise rollup. He has also been active in real estate investing and startups.

Bob Jacobs

President Consumer Products

Bob is a consumer products veteran with 20+ years experience working in various roles at Procter and Gamble. In addition, he has experience across various industries, serving as Chief Brand Officer for Volvo Car Group – Americas and a brand leader at Starwood Hotels.

Dr. Thierry Saint-Denis

Chief Scientific Officer

Thierry has 25 years of experience leading Nutrition Science, Innovation, and Product Development teams in the Food & Beverage industry. He is named inventor in multiple patents in the fields of functional foods & beverages, and in the past 10 years, he spearheaded the design and launch of several blockbuster food products that are consumed by millions of consumers every day.

Peter Kozak PhD.

Head of Engineering

Peter has a PhD in Mechanical and Aerospace Engineering from Illinois Institute of Technology and a BS from the University of Arizona. He brings years of experience in Fluid Dynamics, working for Argonne National Labs on nuclear centrifuge and wind turbine design.

Our Advisors

EdmondsChris_web2

Chris Edmonds

Investor Advisor
Is the Global Head of Clearing & Risk at Intercontinental Exchange, Inc. (NYSE: ICE). Edmonds oversees all of ICE’s clearing house operations and the global risk management team. He serves as Chairman of Hydrosome Labs, LLC
JamesChow

James Chow

Investor Advisor
James Chow is Chief Financial Officer at Oak Street Health. Prior to Oak Street, James spent over 20 years in different leadership roles in startups and turnarounds in the managed care space. He is a Certified Public Accountant
CBL_5

Chris Lorenzen

Investor Advisor
Founder and Chief Executive Officer of Eagle Seven Holdings, LP which includes Eagle Seven, LLC and Eagle Seven Technologies, LLC both based in Chicago, Illinois.  Chris has spent his entire career involved in nearly every aspect of trading and technology from equities to derivatives.
AufieroTina_web2

Martina F. Aufiero

Advisor
Chief Financial Officer at Isoolate, an innovative technology startup. Tina has 20+ years of experience in the Technology sector as both an Investor & Operator. Tina has held numerous board positions and has been an advisor to several tech accelerators. She has been named to the Institutional Investors' FinTech Finance 40.

Our Scientific Advisors

ZentnerGaylen_web2

Gaylen M. Zentner PhD.

Scientific Advisor
Dr. Zentner holds a Ph.D. in Pharmaceutical Chemistry from the University of Utah. Scientific expertise is focused on formulation development and all technical activities supporting both drug substance and drug product sections of Chemistry, Manufacturing & Control (CMC) regulatory submissions where he has 40 years of pertinent experience.
RusconiBill_0821web2

William Rusconi

Scientific Advisor
Bill has over 30 years’ experience in drug, device, diagnostics and consumer products and has held senior management positions ranging from start-ups to the Fortune 50 including, Procter and Gamble, Baxter Healthcare and Myriad Genetics. Mr. Rusconi earned his BS in Molecular Biology from Vanderbilt University and MBA from the Kellogg Graduate School of Management at Northwestern University

We Are Looking
for Partners

We believe our technology has the potential to disrupt categories and are looking for partners to develop and commercialize Hydrosome H20® within their products and operations